Who owns Theriva Biologics, Inc.? Owners, funding and legal record

Before you sign or pay

• Court and bankruptcy: No federal court case or bankruptcy filing found under Theriva Biologics, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
• Layoffs: 1 exit or restructuring plan reported on Form 8-K, Item 2.05 (latest filed 2025-10-02).
• Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Jeffrey Matthew Gryga Irrevocable Trust (filed 2025-11-10).

Who is behind it

Theriva Biologics, Inc.: incorporated in Nevada; business address in Rockville, Maryland; industry Pharmaceutical Preparations (Schedule 13G, 2025-11-10).

Officers and directors, each with the role and the filing that names them:

• Steven A. Shallcross: Executive Officer, Director (Form D, 2025-10-24)
• Jeffrey J. Kraws: Director (Form D, 2025-10-24)
• John Monahan: Director (Form D, 2025-10-24)
• Jeffrey A. Wolf: Director (Form D, 2025-10-24)

Money raised

Latest IPO step: Theriva Biologics, Inc. amended its IPO registration (S-1/A, 2025-03-21).

IPO filings: S-1/A, 2025-03-21, S-1/A, 2025-01-21, S-1, 2024-12-10, S-1/A, 2024-09-23, S-1, 2024-09-10; ticker TOVX on NYSE American.

Red flags found

1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2025-10-02).

Related pages

Layoffs5%+ holders

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

All companies

Not for employment, credit, insurance or tenancy decisions.